Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Germ cell-less protein-like 2 (GMCL2) is a protein-coding gene with probable function in spermatogenesis and transcriptional repression. GMCL2 is likely a substrate-specific adapter of an E3 ubiquitin-protein ligase complex, mediating the ubiquitination and proteasomal degradation of target proteins. It shares high sequence homology with other germ cell-less genes and may play conserved roles across species in germ cell formation and development[3][1]. In model organisms (e.g., Drosophila), related homologs are essential for proper primordial germ cell specification by regulating centrosome dynamics and transcriptional silencing, but GMCL2-specific functions in humans or mammals are less defined[1][3]. No direct evidence currently links GMCL2 to disease, drug interaction, or clinical biomarker use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Germ cell-less protein-like 2 (GMCL2).